Management of withdrawal of opiates and barbiturates
Radelat, F.A.
Texas Medicine 68(3): 112-114
1972
ISSN/ISBN: 0040-4470 PMID: 5012885 Document Number: 46284
Document emailed within 1 workday
Related Documents
Lambert, H.; Kierzek, B.; Demogeot, C.; Larcan, A. 1984: Withdrawal of drug addicts from opiates in general hospitals. Value of clonidine--30 cases Therapie 39(4): 411-419Getova, D.; Georgiev, V. 1987: GABA-ergic mechanisms in the anticonvulsive activity of newly-synthesized barbiturates. I. Effects of barbiturates on the convulsive action of GABA-antagonists Acta Physiologica et Pharmacologica Bulgarica 13(3): 43-50
Tóth-Daru, P.; Sichez, J.P.; Pertuiset, B. 1984: Management of patients with severe brain injuries. Drainage of cerebrospinal fluid from the ventricles and administration of barbiturates Orvosi Hetilap 125(11): 623-628
Delic, M. 2019: Inpatient management of GHB/GBL withdrawal Psychiatria Danubina 31(Suppl 3): 354-356
Komiyama, T. 1997: Clinical features of alcoholics after alcohol withdrawal--withdrawal syndrome, protracted withdrawal syndrome and prolonged disturbance of alcohol dependence Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 393-405
Naik, P.; Lawton, J. 1993: Pharmacological management of alcohol withdrawal British Journal of Hospital Medicine 50(5): 265-269
Castaneda, R.; Cushman, P. 1989: Alcohol withdrawal: a review of clinical management Journal of Clinical Psychiatry 50(8): 278-284
Alpert, M.A. 1985: Alcohol withdrawal syndromes. Part II: Management Missouri Medicine 82(3): 140-144
Nathenson, G.; Golden, G.S.; Litt, I.F. 1971: Diazepam in the management of the neonatal narcotic withdrawal syndrome Pediatrics 48(4): 523-527
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Brett, J.; Lawrence, L.; Ivers, R.; Conigrave, K. 2014: Outpatient alcohol withdrawal management for Aboriginal and Torres Strait Islander peoples Australian Family Physician 43(8): 563-566
Gillmer, R.E. 1973: Benzoctamine and oxazepam in the management of alcohol withdrawal states. Comparison by double-blind trial South African Medical Journal 47(47): 2267-2268
Levy, R.; le Maignan, C.; N'Daw, D.; Andrieu, J.M. 1997: An equivalent of anti-androgen withdrawal syndrome: decrease of prostate specific antigen and clinical response to estramustine phosphate withdrawal Presse Medicale 26(13): 611
McLean, W.; Boucher, E.A.; Brennan, M.; Holbrook, A.; Orser, R.; Peachey, J.; Sellers, E. 2000: Is there an indication for the use of barbiturate-containing analgesic agents in the treatment of pain? Guidelines for their safe use and withdrawal management. Canadian Pharmacists Association Canadian Journal of Clinical Pharmacology 7(4): 191-197
Davis, D.B.; Bellows, J.G. 1977: Endogenous opiates Comprehensive Therapy 3(8): 3-4
Langwiński, R. 1983: Opiates and their antagonists Polski Tygodnik Lekarski 38(51-52): 1625-1629
Haubold, G. 1985: Biosynthesis of endogenous opiates Medizinische Monatsschrift für Pharmazeuten 8(10): 301-303
Saavedra, H.; Ligueros, M.; Báez, M.A.; Paeile, C. 1989: The use of opiates in hospital practice Revista Medica de Chile 116(6): 532-537
Bergmann, H. 1981: Barbiturates Klinische Anasthesiologie und Intensivtherapie 23: 94-106
Sampson, I. 1983: Barbiturates Mount Sinai Journal of Medicine new York 50(4): 283-288